Metrion Biosciences invests in new High Throughput Screening capability and expanded facilities

Glass laboratory flasks on light table

Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service.

Tricky terrain is no problem for this four-legged robot

Previous article

If There Is Phosphine on Venus, There Isn’t Much

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News